Search for: "Abbott Laboratories v. Mylan Pharmaceuticals, Inc."
Results 1 - 20
of 43
Sorted by Relevance
|
Sort by Date
17 Feb 2010, 8:00 am
(patent infringement) 1/22: Abbott Laboratories and Abbott Respiratory LLC v. [read post]
1 Dec 2009, 9:45 am
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
5 May 2010, 4:46 am
Mylan Pharmaceuticals Inc. et al. [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
23 Jun 2010, 10:28 pm
Mylan Inc. et al. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) EU: ‘Victory’ against biopiracy - EPO revokes Schwabe Pharmaceuticals' pelargonium extract patent (Spicy IP) (IP Watch) General Another case for indigenous knowledge protection, but how? [read post]
15 Jun 2011, 4:56 am
Mylan Inc. et al. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc.; Abbott Laboratories et al. v. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of… [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic… [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
